SCM Lifescience Co., Ltd. (KOSDAQ:298060)

South Korea flag South Korea · Delayed Price · Currency is KRW
823.00
-37.00 (-4.30%)
At close: Mar 9, 2026
-32.26%
Market Cap 36.38B
Revenue (ttm) 1.54B
Net Income (ttm) -8.24B
Shares Out 44.20M
EPS (ttm) -362.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 71,704
Average Volume 307,981
Open 853.00
Previous Close 860.00
Day's Range 800.00 - 853.00
52-Week Range 777.00 - 1,675.00
Beta 0.75
RSI 43.13
Earnings Date n/a

About SCM Lifescience

SCM Lifescience Co., Ltd. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief. The company was founded in 2014 and is headquartered in Incheon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 298060
Full Company Profile

Financial Performance

In 2024, SCM Lifescience's revenue was 824.80 million, an increase of 18.56% compared to the previous year's 695.70 million. Losses were -12.38 billion, -48.35% less than in 2023.

Financial Statements

News

There is no news available yet.